§ Mr. Meacherasked the Chancellor of the Exchequer what evidence he has regarding the prevalence of transfer pricing by international companies and in view of the Monopolies Commission's 384W revelations regarding the pricing structures of Roche Products, and what plans he has to survey the comparable activities of other similar companies.
§ Mr. Nott, pursuant to his reply [OFFICIAL REPORT, 19th October 1973; Vol. 861, c. 336], gave the following information:
The transfer prices used in transactions involving United Kingdom resident companies belonging to international groups and their non-resident associates can be, and in appropriate cases are, challenged under tax and exchange legislation. I cannot of course make any statement about the application of the law to particular companies.